Abstract
Silymarin, a polyphenolic flavonoid antioxidant, is known to have anti-inflammatory, hepatoprotective, and anticarcinogenic effects. In the present study, we report the inhibitory effect of silymarin on nitric oxide production and inducible nitric-oxide synthase (iNOS) gene expression in macrophages. In vivo administration of silymarin attenuated nitric oxide production by peritoneal macrophages in lipopolysaccharide (LPS)-treated mice. Silymarin also dose dependently suppressed the LPS-induced production of nitric oxide in isolated mouse peritoneal macrophages and RAW 264.7, a murine macrophage-like cell line. Moreover, iNOS mRNA and its protein expression were completely abrogated by silymarin in LPS-stimulated RAW 264.7 cells. To further investigate the mechanism responsible for the inhibition of iNOS gene expression by silymarin, we examined the effect of silymarin on LPS-induced nuclear factor-κB (NF-κB)/Rel activation, which regulates various genes involved in immune and inflammatory response. In RAW 264.7 cells, the LPS-induced DNA binding activity of NF-κB/Rel was significantly inhibited by silymarin, and this effect was mediated through the inhibition of the degradation of inhibitory factor-κB. Silymarin also inhibited tumor necrosis factor-α-induced NF-κB/Rel activation, whereas okadaic acid-induced NF-κB/Rel activation was not affected. NF-κB/Rel-dependent reporter gene expression was also suppressed by silymarin in LPS-stimulated RAW 264.7 cells. Further study showed that silymarin suppressed the production of reactive oxygen species generated by H2O2 in RAW 264.7 cells. Collectively, these results suggest that silymarin inhibits nitric oxide production and iNOS gene expression by inhibiting NF-κB/Rel activation. Furthermore, the radical-scavenging activity of silymarin may explain its inhibitory effect on NF-κB/Rel activation.
Footnotes
- Abbreviations:
- NO
- nitric oxide
- NOS
- nitric-oxide synthase
- iNOS
- inducible nitric-oxide synthase
- LPS
- lipopolysaccharide
- NF-κB
- nuclear factor-κB
- IκB
- inhibitory factor-κB
- TNF-α
- tumor necrosis factor-α
- RT-PCR
- reverse transcription-polymerase chain reaction
- PCR
- polymerase chain reaction
- Erk
- extracellular signal-regulated kinase
- SAPK
- stress-activated protein kinase
- JNK
- c-Jun N-terminal kinase
- MAP
- mitogen-activated protein kinase
- CAT
- chloramphenicol acetyltransferase
- DCFH-DA
- 2′,7′-dichlorofluorescin diacetate
- ROS
- reactive oxygen species
- PMA
- phorbol-12-myristate-13-acetate
- A23187
- calcimycin
- Received January 23, 2002.
- Accepted March 15, 2002.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|